If, like me, you made a lot of money from Intellectualvalue's heads-up on Friday about the reexams, you may be interested in the latest story posted there. A patent company called LML Payments (ticker LMLP) just got their reexam closed with all claims in their key patent rejected. The stock already tanked once on bad reexam news. No options available for LMLP. Story here:
Yeah, the price seems to be based on high expectations of litigation damages or settlements. If you read through what the patent office said it is pretty clear that their patent is dead and their litigation is all based on this. This stock is at $4.50 but was $1.50 less than 6 months ago.